COVID-19 and ‘stem cell’ research: Does the hype match the reality?

“Scientists, regulators, and policymakers must guard against the proliferation of poorly designed, underpowered, and duplicative studies that are launched with undue haste because of the pandemic, but are unlikely to provide convincing, clinically meaningful safety and efficacy data,” said co-author Leigh Turner, professor of Health, Society and Behavior at the University of California, Irvine.